Dracorhodin targeting CMPK2 attenuates inflammation: A novel approach to sepsis therapy

BACKGROUND: Despite all modern advances in medicine, an effective drug for treating sepsis has yet to be found. The discovery of CMPK2 spurred hopes for the treatment of sepsis. However, CMPK2‐untapped target inhibitors are still an enormous obstacle that has hindered the CMPK2‐centric treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wendan, Jiang, Honghong, Huang, Pengli, Wu, Gaosong, Wang, Qun, Luan, Xin, Zhang, Hongwei, Yu, Dianping, Wang, Hongru, Lu, Dong, Wang, Haonan, An, Huazhang, Liu, Sanhong, Zhang, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587737/
https://www.ncbi.nlm.nih.gov/pubmed/37859535
http://dx.doi.org/10.1002/ctm2.1449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587737/
https://www.ncbi.nlm.nih.gov/pubmed/37859535
http://dx.doi.org/10.1002/ctm2.1449

Ejemplares similares